Editorial: Hepatic steatosis, insulin resistance, and adipose tissue disorders

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 7, 2002, Pages 3019-3022

  Garg, Abhimanyu ^a,b   Misra, Anoop ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LAMIN A; LAMIN C; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; EDITORIAL; FATTY LIVER; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; LIPODYSTROPHY; LIVER BIOPSY; LIVER WEIGHT; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; VALIDATION PROCESS; HUMAN; NOTE; PATHOPHYSIOLOGY;

FATTY LIVER; HUMANS; INSULIN RESISTANCE; LIPODYSTROPHY; OBESITY;

EID: 85047681686     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.7.8736     Document Type: Editorial

References (48)

1. Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
2. Liver pathology and the metabolic syndrome X in severe obesity
3. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
4. Nonalcoholic steatohepatitis and hepatocellular carcinoma: Natural history?
5. Relative risk of hepatocellular carcinoma in cirrhosis due to fatty liver disease: A study based on incidental hepatocellular carcinoma in liver transplant receipients
6. Hepatocellular carcinoma, liver failure and liver mortality in obesity-related cryptogenic cirrhosis
7. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
8. Insulin resistance in non-alcoholic steatohepatitis
9. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
10. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome
11. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
12. Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight
13. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
14. Nonalcoholic steatohepatitis: An expanded clinical entity
15. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes
16. Relationship of generalized and regional adiposity to insulin sensitivity in men
17. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM
18. Measurement of intracellular triglyceride stores by H spectroscopy: Validation in vivo
19. Quantification of liver fat using magnetic resonance spectroscopy
20. Fatty liver: Biochemical and clinical considerations
21. 1H localized magnetic resonance spectroscopy and comparison with computed tomography
22. Noninvasive in vivo quantitative assessment of fat content in human liver
23. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men
24. On the practice of dichotomization of quantitative variables
25. Bivariate median splits and spurious statistical significance
26. Reporting on statistical methods to adjust for confounding: A cross-sectional survey
27. Non alcoholic fatty liver disease
28. Lipodystrophies
29. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 30-1976
30. Congenital generalized lipodystrophy. Report on one case, with special reference to postmortem findings
31. Postmortem findings in familial partial lipodystrophy, Dunnigan variety
32. Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation
33. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34
34. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13
35. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy
36. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C
37. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
38. A novel heterozygous mutation in peroxisome proliferator-activated receptor-γ gene in a patient with familial partial lipodystrophy
39. A novel interaction between lamin A and SREBP1: Implications for partial lipodystrophy and other laminopathies
40. Serum leptin levels in patients with nonalcoholic steatohepatitis
41. Relationship between serum leptin and fatty liver in Japanese male adolescent university students
42. Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects
43. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
44. Congenital leptin deficiency is associated with severe early-onset obesity in humans
45. A leptin missense mutation associated with hypogonadism and morbid obesity
46. Leptin-replacement therapy for lipodystrophy
47. Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy
48. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy